pharma · Graft Rejection · Arrhythmias
Wyeth is now
Wyeth is now a wholly owned subsidiary of Pfizer
Wyeth is now clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 9
- Drugs
- 8
- Patents
- 0
Wyeth is now projects
0 ClinicalTrials.gov programs sponsored by Wyeth is now.
Wyeth is now has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
No programs matched
Frequently asked questions
How many clinical projects does Wyeth is now have?
0 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.